Literature DB >> 22337206

Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China.

Wen J Ma1, Jin L Tang, Yong H Zhang, Yan J Xu, Jin Y Lin, Jian S Li, Xiang Q Lao, Wilson W S Tam, Martin C S Wong, Ignatius T S Yu.   

Abstract

BACKGROUND: Hypertension is the most important risk factor for cardiovascular diseases. Little information exists on the status of hypertension among southern Chinese. We therefore investigated the hypertension prevalence, awareness, treatment, control, and associated factors in a southern Chinese population with 85 million residents.
METHODS: Stratified multistage cluster sampling with probability proportional to size method was used in this survey. A representative sample of 13,889 residents aged 20 years or above with completed questionnaire and blood pressure (BP) measurement was obtained. BP was measured in accordance with the 1999 World Health Organization/International Society of Hypertension Guidelines. Information related to history of diagnosis and treatment of hypertension was collected through questionnaire.
RESULTS: The prevalence of hypertension in this population was 20.5% (16.5%, 24.4%), which translated to 9.8 million adults suffering from hypertension in Guangdong province. The urban population had higher prevalence of hypertension than the rural population (25.1 vs. 16.1%). The prevalence of awareness, treatment, and control of hypertension in hypertensive patients living in urban regions were 42.8, 37.9, and 13.5%, respectively, which were higher than those in rural regions (the corresponding figures were 17.6, 10.4, and 3.4%, respectively). Nearly 50% urban adults and 80% rural adults did not measure their BP in the last 12 months. Frequency of BP measurement was associated with both awareness and treatment.
CONCLUSIONS: Hypertension was prevalent in southern China. The prevalence of awareness, treatment, and control of hypertension is low. Urgent strategies are needed to improve prevention, detection, and treatment of hypertension in this large Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337206     DOI: 10.1038/ajh.2012.11

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  39 in total

1.  Overall obesity is leveling-off while abdominal obesity continues to rise in a Chinese population experiencing rapid economic development: analysis of serial cross-sectional health survey data 2002-2010.

Authors:  X Q Lao; W J Ma; T Sobko; Y H Zhang; Y J Xu; X J Xu; D M Yu; S P Nie; Q M Cai; L Xia; G N Thomas; S M Griffiths
Journal:  Int J Obes (Lond)       Date:  2014-05-26       Impact factor: 5.095

2.  Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases.

Authors:  Vilma E Irazola; Laura Gutierrez; Gerald Bloomfield; Rodrigo M Carrillo-Larco; Prabhakaran Dorairaj; Thomas Gaziano; Naomi S Levitt; J Jaime Miranda; Antonio Bernabe Ortiz; Krisela Steyn; Yangfeng Wu; Denis Xavier; Lijing L Yan; Jiang He; Adolfo Rubinstein
Journal:  Glob Heart       Date:  2016-03

3.  Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population.

Authors:  D Busingye; S Arabshahi; R G Evans; V K Srikanth; K Kartik; K Kalyanram; M A Riddell; X Zhu; O Suresh; A G Thrift
Journal:  J Hum Hypertens       Date:  2017-01-05       Impact factor: 3.012

4.  The healthcare burden of hypertension in Asia.

Authors:  Chun-Na Jin; Cheuk-Man Yu; Jing-Ping Sun; Fang Fang; Yong-Na Wen; Ming Liu; Alex Pui-Wai Lee
Journal:  Heart Asia       Date:  2013-11-19

5.  Combined effect of obesity and low physical performance on the incidence of hypertension in Chinese community-dwelling older population.

Authors:  Yuewen Liu; Yaoxin Chen; Peipei Han; Weibo Ma; Ming Cai; Feng Wang; Jingru Wang; Jinyu Zhang; Wen He; Xiaoyi Zhu; Qi Guo; Ying Yu
Journal:  J Hum Hypertens       Date:  2020-11-18       Impact factor: 3.012

6.  Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.

Authors:  Shing Fung Lee; Miguel Angel Luque-Fernandez; Yu Hui Chen; Paul J Catalano; Chi Leung Chiang; Eric Yuk-Fai Wan; Ian Chi-Kei Wong; Ming Hui Chen; Andrea K Ng
Journal:  Blood Adv       Date:  2020-10-27

7.  General practitioners' hypertension knowledge and training needs: a survey in Xuhui district, Shanghai.

Authors:  Qian Chen; Xiangjie Zhang; Jie Gu; Tianhao Wang; Yuan Zhang; Shanzhu Zhu
Journal:  BMC Fam Pract       Date:  2013-01-28       Impact factor: 2.497

8.  Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey.

Authors:  Jinwei Wang; Luxia Zhang; Fang Wang; Lisheng Liu; Haiyan Wang
Journal:  Am J Hypertens       Date:  2014-04-03       Impact factor: 2.689

9.  Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study.

Authors:  Xing Lin Feng; Mingfan Pang; John Beard
Journal:  Bull World Health Organ       Date:  2013-09-10       Impact factor: 9.408

10.  Performance comparison among the major healthcare financing systems in six cities of the Pearl River Delta region, mainland China.

Authors:  Martin C S Wong; Harry H X Wang; Samuel Y S Wong; Xiaolin Wei; Nan Yang; Zhenzhen Zhang; Haitao Li; Yang Gao; Donald K T Li; Jinling Tang; Jiaji Wang; Sian M Griffiths
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.